Study to prevent dangerous blood clots during pregnancy
Part of Heart & circulation clinical trials.
This study looks at pregnancy-related risk for a dangerous blood clot in the leg or lung (venous thromboembolism). It focuses on pregnant people who already have a higher-than-average risk and wants to see how to manage that risk safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and an adult.
- You are no more than 7 months pregnant when you join.
- You have a personal history of a prior blood clot and/or a clotting-condition (thrombophilia).
- You can safely take heparin (or you do not have a known reason you cannot take it).
- You do not only have pregnancy complications without a prior blood clot (like pre-eclampsia, HELLP, or miscarriage).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how pregnancy affects blood clots in healthy women. If you qualify, researchers will check your blood's clotting properties to learn more about pregnancy-related changes.
This study looks at the best way to manage blood thinners for pregnant people who have mechanical heart valves. It aims to find the safest approach for both the mother and the baby.
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
This study looks at the best way to manage blood thinners (like injections of LMWH) during pregnancy for people who need them because of a past or current blood clot risk. It may help by improving how safely and effectively anticoagulation is handled to reduce clot complications.
This study tests whether giving a short course of a daily blood-thinning injection (enoxaparin) after childbirth can safely prevent blood clots in women at intermediate risk. If you qualify, you would receive the injection or a placebo (inactive shot) for up to 5 days while in the hospital.
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
Hear when a new Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.